Delivery Order SPE2DB22D3401-SPE2DB25FT3YG

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,145.91 firm-fixed-price award is for the delivery of TWINRIX VACCINE, a hepatitis A and hepatitis B vaccine, to support medical treatment facilities. The contract has an ultimate completion date of August 30, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $14,477.01, is for the supply of the TWINRIX vaccine, a combination hepatitis A and hepatitis B vaccine, to support federal healthcare programs. The Firm Fixed Price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of TWINRIX Vaccine syringes, a vaccine used for the prevention of hepatitis A and hepatitis B. The contract has a ceiling value of $2,705.52 and runs through February 8, 2024. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX VACCINE SYRINGEml, a hepatitis A and hepatitis B vaccine, with a ceiling value of $1,078.23 and a period of performance through April 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $21,138.67 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the TWINRIX vaccine, which is a combination hepatitis A and hepatitis B vaccine administered via syringe. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under an Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $100,636.46, is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $13,656.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX vaccine syringes, a vaccine for Hepatitis A and Hepatitis B. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of August 28, 2024. It is not designated as a Set-Aside contract, indicating open...
This federal contract award is a delivery order with a ceiling value of $69,912.10, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the TWINRIX vaccine, a hepatitis A and hepatitis B combination vaccine, to support military healthcare programs. The contract has a period of performance through April 16, 2024, and was awarded on April 15, 2024. This contract is not designated as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the TWINRIX VACCINE SYRINGE, a combination hepatitis A and hepatitis B vaccine, with a ceiling value of $3,639.25 and a period of performance through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $78,703.06 firm fixed-price delivery order is for the TWINRIX vaccine, a hepatitis A and hepatitis B combination vaccine, to be delivered by December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT3YG
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the TWINRIX vaccine, a combined hepatitis A and hepatitis B vaccine, with a ceiling value of $7,895.37. The contract is a Firm Fixed Price (FFP) delivery order with a completion date of May 29, 2025. The contract is not set aside and is open to full and open competition. As a critical supplier of medical and pharmaceutical products to federal agencies, particularly the Department of Defense, AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00, which enables the company to provide a wide range of pharmaceutical and medical supplies to support military healthcare programs worldwide.

Generated 8/27/25, 9:43 AM